Success Stories: Strategic NIW Approval Achieved for Research Scientist in Biomedicine

Posted by wegreened on July 10, 2025 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“I would like to sincerely express my gratitude for your great service and your assistance throughout the process.”

On April 17^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biomedicine (Approval Notice).

General Field: Biomedicine

Position at the Time of Case Filing: Research Scientist

Country of Origin: Iran

Country of Residence at the Time of Filing: Germany

Approval Notice Date: April 17^th, 2025

Processing Time: 5 months, 12 days

Case Summary:

When a research scientist approached NAILG for assistance with his NIW petition, he was already recognized for his significant contributions to the field of molecular biomedicine. Specializing in nanoparticle-based delivery systems, his research focuses on improving targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy. His work aims to enhance therapeutic efficacy while reducing the side effects traditionally associated with these treatments - a vital development for advancing cancer care.

NAILG guided our client through the NIW petition process, ensuring that his expertise in nanoparticle-based delivery systems was positioned as both innovative and crucial to U.S. health priorities. We crafted a petition that highlighted the national importance of his research in the context of cancer treatment and oncology breakthroughs.

His Major Achievements Include:

❖ 7 peer-reviewed journal articles, with 5 first-authored, contributing to his leadership in the field

❖ 2 first-authored conference abstracts, showcasing his active involvement in scientific discussions

❖ 142 citations, signaling his growing influence in molecular biomedicine

❖ 7 peer reviews conducted, reinforcing his reputation as an expert in biomedical research

Our client’s innovations in nanoparticle delivery systems are at the cutting edge of cancer treatment, offering potential advancements that could revolutionize how therapies are delivered to patients. His research has global implications for improving cancer treatment precision, reducing side effects, and enhancing patient quality of life.

NAILG’s role was crucial in ensuring that his NIW petition effectively communicated the national significance of his research. Our strategic support emphasized how his work aligns with the U.S. health priorities and its potential for lasting impact on both medical science and patient outcomes. The petition not only underscored his exceptional ability but also reinforced his commitment to advancing the future of cancer care in the U.S.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%